Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study.
Saved in:
| Title: | Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study. |
|---|---|
| Authors: | Sarva H; Parkinson's Disease & Movement Disorders Institute, Weill Cornell Medicine, New York, NY, USA., Pahwa R; University of Kansas Medical Center, Kansas City, Kansas, USA., Hernandez-Vara J; Neurology Department, Vall D´Hebron University Hospital, Neurodegenerative Diseases Research Group. Vall D´Hebron Research Institute (VHIR), Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain., Goldstein MA; JEM Research Institute, 130 JFK Drive, Atlantis, FL, USA., Borgohain R; Parkinson's Disease and Movement Disorders Research Center, Yashoda Hospital, Hitec City, Hyderabad, India., Factor SA; Emory University School of Medicine, Atlanta, GA, USA., Inamdar S; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Love D; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Hames C; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Fu Y; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Mergel V; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Goldfine A; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Kumar C; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Piccoli SP; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Yao SL; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA., Hurko O; Sun Pharma Advanced Research Company Ltd, Cranbury, NJ, USA. orest.hurko@sparcmail.com.; Tufts University Medical Center, Graduate School of Biomedical Sciences, Boston, MA, USA. orest.hurko@sparcmail.com. |
| Source: | NPJ Parkinson's disease [NPJ Parkinsons Dis] 2026 Feb 03; Vol. 12 (1). Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101675390 Publication Model: Electronic Cited Medium: Print ISSN: 2373-8057 (Print) Linking ISSN: 23738057 NLM ISO Abbreviation: NPJ Parkinsons Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2373-8057 |
|---|---|
| DOI: | 10.1038/s41531-026-01275-1 |
